Trial intelligence / Profile preview

Pharmacokinetics of antituberculosis drugs in Thai population

TCTR20210323004Not yet recruiting

Sponsor
Chulalongkorn University
Start
Apr 2021
Countries
1
01

Overview

Open-label, single-arm trial in Tuberculosis (TB), sponsored by Chulalongkorn University. Primary endpoint: Pharmacokinetic parameters of antituberculosis drugs. Planned start Apr 2021; status: not yet recruiting.

02

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on TCTR20210323004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210323004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call